Cathepsin B-cleavable doxorubicin prodrugs for targeted cancer therapy (Review)

Author：

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.42, Iss.2, 2013-01, pp. : 373-383

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted therapy against cancer stem cells (Review)

By Yang Tao Rycaj Kiera

Oncology Letters, Vol. 10, Iss. 1, 2015-07 ,pp. : 27-33

Spandidos Publications

Access to resources Recommend Favorite

Hypoxia-activated prodrugs in cancer therapy: progress to the clinic

By Denny William A

Future Oncology, Vol. 6, Iss. 3, 2010-03 ,pp. : 419-428

Future Medicine

Access to resources Recommend Favorite

Recent Advances in Small Molecule Prodrugs for Cancer Therapy

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 3, 2014-03 ,pp. : 418-439

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Nanosystems for Cancer Therapy

Current Cancer Therapy Reviews, Vol. 13, Iss. 1, 2017-08 ,pp. : 63-73

Bentham Science Publishers

Access to resources Recommend Favorite

The contribution of antibodies to targeted cancer therapy

By Apostolou Panagiotis Papasotiriou Ioannis

memo - Magazine of European Medical Oncology, Vol. 6, Iss. 4, 2013-12 ,pp. : 258-261

Springer Publishing Company

Access to resources Recommend Favorite